Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA Announces Pricing of Offering of Senior Notes
10:58pm, Wednesday, 10'th Jun 2020
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000,000 in...
IQVIA : Announces Pricing of Offering of Senior Notes | MarketScreener
09:59pm, Wednesday, 10'th Jun 2020NANOBIOTIX : Curadigm valide sa technologie Nanoprimer dans les thérapies à base d'ARN | Zone bourse
06:20am, Wednesday, 10'th Jun 2020Nanobiotix : LA FILIALE DE NANOBIOTIX CURADIGM VALIDE SA TECHNOLOGIE NOVATRICE NANOPRIMER DANS LES THERAPIES A BASE D'ARN | Zone bourse
06:01am, Wednesday, 10'th Jun 2020Zacks: Brokerages Expect Iqvia Holdings Inc (NYSE:IQV) to Announce $1.05 EPS
06:00am, Wednesday, 10'th Jun 2020
Equities analysts predict that Iqvia Holdings Inc (NYSE:IQV) will report earnings per share of $1.05 for the current quarter, according to Zacks. Seven analysts have made estimates for Iqvia’s earni
AroCell publ : TK1 measurements in serum correlate with the treatment response in breast cancer patients | MarketScreener
02:48pm, Tuesday, 09'th Jun 2020IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes
01:24pm, Tuesday, 09'th Jun 2020
Moody's Investors Service ("Moody's") assigned a Ba3 rating to the proposed senior unsecured notes of IQVIA Inc. ("IQVIA"). There are no changes to IQVIA's existing ratings, including the Ba2 Corpora
IQVIA UK Regulatory Announcement: IQVIA Announces Offering of Senior Notes
12:00am, Tuesday, 09'th Jun 2020
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $800,000,000
Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology’s Standard of Care with Genomics Technology Collaboration
12:00pm, Wednesday, 03'rd Jun 2020
Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its partnership with Thermo Fisher Scientific to us
Global Pharmaceutical Glass Packaging Market (2020 to 2025) - Growth, Trends and Forecast - ResearchAndMarkets.com
12:00am, Wednesday, 03'rd Jun 2020
The
Forget IQVIA, Veeva Systems Is a Better Growth Stock
02:58pm, Tuesday, 02'nd Jun 2020
Here’s why Veeva Systems is the better choice for investors looking for exposure to companies performing clinical trial analytics.
Here's Why You Should Hold IQVIA Holdings (IQV) Stock Now
02:07pm, Monday, 01'st Jun 2020
Solid technological suite and growth opportunities from emerging markets are positives for IQVIA Holdings (IQV). However, higher interest expense, seasonality and foreign exchange rate risks persist.
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
10:28am, Monday, 01'st Jun 2020
Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
